Fenofibrate Tablet
Product Images NDC 69097-458

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Fenofibrate (NDC 69097-458). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cipla Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

5793281e 4b4f 44a1 9edd Fc4b2d4630e3 01

FDA Label Image

5793281e 4b4f 44a1 9edd Fc4b2d4630e3 02

This is a description of a medication containing fenofibrate, with details on the packaging and dispensing. The medication comes in tablet form and should not be accepted if the seal over the bottle opening is broken or missing. The tablets come in a container with a package insert providing full prescribing information. The medication should be stored at 25°C with excursions permitted to 15°C-30°C. The medication should be protected from moisture. The text includes the drug's manufacturer and a physical address. There is also mention of batch overprinting with a serial number and expiration date.*

FDA Label Image

5793281e 4b4f 44a1 9edd Fc4b2d4630e3 03

Each film coated tablet contains 145mg of Fenofibrate USP, which is dispensed in a USP tight container. The tablets are manufactured by Cipla Ltd. in India and distributed to the USA by Cipla USA, Inc. The tablets should be stored at 25°C (77°F) with excursions permitted to 15°C to 30°C (59°F to 86°F) and protected from moisture. Full prescribing information is available in the package insert. The NDC number is 69097-458-02 and it is available by prescription only. If the seal over the bottle opening is broken or missing, do not accept.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.